Product information

Current status:

Cancelled Pre Market

Current status date:

2017-08-01

Original market date: ^{See footnote 1}

Product name:

HISTAMINE PHOSPHATE INJECTION USP, 1MG/ML

DIN:

02300427 Electronic product monograph is not available

Company:

ALVEDA PHARMACEUTICALS INC
5995 Avebury Road, Suite 804
Mississauga
Ontario
Canada L5R 3P9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

36:36.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V04CG03 HISTAMINE

Active ingredient group (AIG) number:^{See footnote5}

0107535003